Takeda To Make Millennium Global Headquarters For Oncology Drugs
This article was originally published in PharmAsia News
Executive Summary
As part of a managerial shakeup, Takeda Pharmaceutical plans to make its Millennium Pharmaceuticals subsidiary in the U.S. its global headquarters for oncology drugs.